Support independent, student-run journalism.

Your support helps give staff members from all backgrounds the opportunity to conduct meaningful reporting on important issues at Stanford. All contributions are tax-deductible.

Stanford researchers use stem cells to create pure populations of human cell types

Researchers at the Stanford University School of Medicine have discovered the combinations of biological and chemical signals needed to rapidly generate human cell types from human embryonic stem cells, according to Stanford Medicine News. Pure populations of up to 12 cell types can now be created in five to nine days, as opposed to the weeks or months previously required.

New Stanford regimen eliminates kidney-transplant patients’ dependency on drugs

Researchers at the School of Medicine recently developed a new procedure designed to remove kidney-transplant patients’ dependency on immune-suppressing drugs. Transplant recipients must typically continue to take two to three immune system suppressing drugs for the remainder of their lives, following the transplant procedure. While the drugs prevent transplant recipients’ bodies from rejecting the kidney, these drugs include numerous side effects and do not always prevent kidney failure. The new technique differs from standard kidney-transplant procedures by implanting stem cells from the kidney donor’s blood into the transplant recipient’s lymph nodes, spleen and thymus.